Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

VLCC Slapped Rs 3 Lakh Fine Over Misleading CoolSculpting Weight-Loss Ads

Susmita Roy25 Aug 2025 6:30 PM IST

New Delhi: Cracking down on misleading claims in the beauty and wellness industry, the Central Consumer Protection Authority (CCPA) has fined VLCC...

CDSCO Panel Asks Unique Biotech to Submit Approval Status of Bacillus coagulans Unique IS-2 2 Billion CFU

Susmita Roy25 Aug 2025 4:00 PM IST

New Delhi: In line with the proposal regarding the combination of an osmotic laxative and a probiotic, which is Lactulose 10 gm plus Bacillus...

Declare Cancer a Notifiable Disease, Bring Cancer Drugs Under Price Control: Parliamentary Panel

Susmita Roy24 Aug 2025 4:52 PM IST

New Delhi: "Government undertake urgent measures to expand the scope of the Drugs (Prices Control) Order, 2013, to include the widest possible range...

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

Rs 92 Cr Drug Factory Busted in Bhopal: DRI Arrests 7, Exposes International Mephedrone Syndicate

Susmita Roy24 Aug 2025 2:15 PM IST

New Delhi: In a significant crackdown on India's escalating synthetic drug challenge, the Directorate of Revenue Intelligence (DRI) has arrested seven...

Relief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma Trade

Medicines Are Lifelines, Not Luxury: AIOCD Seeks 5% GST on All Medicines, 0% on Life-Saving Drugs

Susmita Roy23 Aug 2025 5:15 PM IST

New Delhi: In a major push for patient relief, the All India Organisation of Chemists and Druggists (AIOCD), representing 12.40 lakh chemists and...

DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&D

Telangana Drug Authority Reports 42,420 Inspections, 186 NSQ Drugs Between 2024-2025, Minister Orders Action

Susmita Roy23 Aug 2025 4:15 PM IST

Hyderabad: The Drug Control Authority (DCA) of Telangana has intensified its enforcement drive, conducting over 42,000 inspections in the last 19...

Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert

Susmita Roy23 Aug 2025 3:00 PM IST

New Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and...

Drugs and Cosmetics Act Set for Fresh Decriminalization Under Jan Vishwas Bill 2025

Susmita Roy21 Aug 2025 7:16 PM IST

New Delhi: The Drugs and Cosmetics Act, 1940, key legislation governing India's pharmaceutical sector, is set for further decriminalization under the...

CDSCO Panel Approves Emcure's Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites

Susmita Roy21 Aug 2025 6:53 PM IST

New Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Susmita Roy20 Aug 2025 4:20 PM IST

New Delhi: Following a thorough discussion on the proposed Phase III clinical trial protocol for roflumilast cream, the Subject Expert Committee (SEC)...

Illegal Alprazolam Unit Busted in Andhra, 8 Arrested, Drugs Worth Rs 24 Crore Seized

Susmita Roy20 Aug 2025 3:58 PM IST

New Delhi: In a major crackdown on the illegal drug trade, the Directorate of Revenue Intelligence (DRI) has discovered a clandestine manufacturing...

Sun Pharma Halol facility gets OAI status from USFDA

Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns

Susmita Roy19 Aug 2025 3:11 PM IST

New Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok